Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Completed

Conditions studied: Kidney Cancer, Renal Cell Carcinoma, Advanced Renal Cell Carcinoma

In brief

Standard treatment for kidney cancer is to remove the tumors from the body with surgery. The purpose of this clinical trial is to collect, preserve, and store excess kidney cancer tumor specimens that would normally be discarded after surgery.

Key facts

Study ID

NCT02143492

Run by

Argos Therapeutics

People needed

11

Starts

2013-08-01

Expected to finish

2015-07-01

Last updated by the study team

2017-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. Age ≥ 18 years
• 2. Diagnosis or clinical signs of advanced RCC (Stage III or IV RCC; Refer to Appendix A)
• 3. Scheduled for cytoreductive or partial (unilateral or bilateral) nephrectomy
• 4. Signed and dated informed consent document indicating that the subject (or legally acceptable representative) has been informed of all pertinent aspects of tumor specimen collection prior to enrollment

You may not qualify if…

• 1. Evidence of brain metastases prior to nephrectomy
• 2. Requirement for systemic chronic immunosuppressive drugs or systemic chronic corticosteroids, for active autoimmune disorder(s) or other conditions (e.g.: rheumatoid arthritis, systemic lupus erythematous, multiple sclerosis, organ transplant recipient, etc.)
• 3. History of HIV infection, or history of chronic infection with Hepatitis B or Hepatitis C

Where it is running

• Study site — Englewood, Colorado, United States
• Study site — Marietta, Georgia, United States
• Study site — Woodbury, Minnesota, United States
• Study site — Rock Hill, North Carolina, United States
• Study site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.